Come up with a name for your new list and we'll add to it:
Intezyne Technologies raised a round of funding on October 06, 2017. Investors include
Gaston Capital Partners.
Intezyne Technologies is dedicated to treating cancer better. Intezyne's nanotechnology platform, the IVECT(TM) Method, can be generated around a broad array of drugs, from small molecules to peptides…